| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +388 K | 100% | $0.45 | +$173 K |
| Sells | 0 | ||||
| Net | +2 | +388 K | 100% | +$173 K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Invus Public Equities, L.P. | 10%+ Owner | $20.3 M | Feb 24, 2023 | ||
| Scott D. Sandell | 10%+ Owner | $5.28 M | Jan 25, 2023 | ||
| Rachel K. King | Director | $1.55 M | May 1, 2024 | ||
| John L. Magnani | SVP of Research, CSO | $875 K | Nov 11, 2022 | ||
| Chinmaya Rath | SVP and Chief Business Officer | $380 K | Jan 12, 2024 | ||
| Bruce S. Johnson | SVP & Chief Commercial Officer | $328 K | Jan 12, 2024 | ||
| Daniel M. Junius | Director | $295 K | May 1, 2024 | ||
| Edwin Rock | Chief Medical Officer | $182 K | +$169 K | +1336% | Jun 20, 2024 |
| Patricia S. Andrews | Director | $138 K | May 1, 2024 | ||
| Mark Alan Goldberg | Director | $109 K | May 1, 2024 | ||
| Scott Koenig | Director | $86.7 K | May 1, 2024 | ||
| Armand Girard | SVP, Chief Business Officer | $68.8 K | Nov 11, 2022 | ||
| Brian M. Hahn | SVP Finance, CFO | $17.5 K | +$4.34 K | +32.9% | Jun 18, 2024 |
| Harout Semerjian | Chief Executive Officer, Director | Jan 12, 2024 | |||
| Timothy R. Pearson | Director | May 1, 2024 | |||
| Scott Thomas Jackson | Director | May 1, 2024 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|